Not Yet Classified

This recall has not yet been classified by risk level.

Mohnark Pharmaceuticals Recalls Lidocaine Topical Anesthetic Cream Due to Failure to Meet Child-Resistant Packaging Requirement; Risk of Poisoning (Recall Alert)

Date: June 30, 2022
Company: Mohnark Pharmaceuticals Inc., of Davie, Fla.
Status: Ongoing
Source: CPSC

What You Should Do

Stop using this product immediately. Do not consume, use, or distribute it.

Consumers should immediately stop using the recalled cream and store it in a location out of sight and reach of children. Contact Mohnark Pharmaceuticals for instructions on how to dispose of the product to receive a full refund. Mohnark Pharmaceuticals is contacting all known purchasers directly. Options: Refund

Affected Products

The recall involves Mohnark Pharmaceuticals Lidocaine 4% Topical Anesthetic Cream. The product was sold in a white tube with a flip-top closure. Mohnark Pharmaceuticals is printed under the blue and green logo on the right side of the product tube. The lot code is located at the bottom of the product tube. The affected lot codes are 01202201, 210201, 210301, 210503, 210505, 210601, 211002 and 210401. The UPC 860002324906 is located on bottom side panel of the packaging.

Why Was This Recalled?

The product contains lidocaine which must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging is not child resistant, posing a risk of poisoning to young children if they ingest the anesthetic cream.

Where Was This Sold?

Distribution information not available.

About Mohnark Pharmaceuticals Inc., of Davie, Fla.

Mohnark Pharmaceuticals Inc., of Davie, Fla. has 1 total recall tracked by RecallDetector.

Related Recalls

Data sourced from the CPSC. Last updated March 26, 2026. View original report